logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Gilead Connecticut, Inc.


USPTO Granted Patents = 30

% Expired Patents = 10.0



Forward Citations = 446

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Scott A Mitchell (23 out of 67 patents)

silverMedal Kevin S Currie (22 out of 72 patents)

bronzeMedal Peter A Blomgren (18 out of 53 patents)

4.  Jeffrey E Kropf (16 out of 45 patents)

5.  Jianjun Xu (16 out of 40 patents)

6.  Seung H Lee (15 out of 37 patents)

7.  Zhongdong Zhao (11 out of 32 patents)

8.  Aaron C Schmitt (9 out of 25 patents)

9.  Douglas Gregory Stafford (8 out of 15 patents)

10.  Pavel E Zhichkin (7 out of 14 patents)

11.  Wendy B Young (7 out of 30 patents)

12.  Xiaojing Wang (6 out of 34 patents)

13.  Daniel Fred Ortwine (5 out of 31 patents)

14.  Antonio J M Barbosa (5 out of 6 patents)

15.  Dimitrios Stefanidis (5 out of 29 patents)


Core Competencies:
Syk Inhibitors
Pyridone Compounds
Imidazopyridines
Polymorphs
Formulations
Pyridazinones
Aza-Pyridones
Imidazopyrazines
Substituted Ureas
Kinase Activity
Substituted Amides
Pyrazoles

30 patents:

1. 10344040 - Pyridone and aza-pyridone compounds and methods of use (2019-07-09),
2. 10266539 - Polymorph of Syk inhibitors (2019-04-23),
3. 10093684 - Substituted imidazo[1,2-a]pyrazines as Syk inhibitors (2018-10-09),
4. 10092583 - Imidazopyridines Syk inhibitors (2018-10-09),
5. 10053469 - Pyridone and aza-pyridone compounds and methods of use (2018-08-21),
6. 9949932 - Formulation of syk inhibitors (2018-04-24),
7. 9918939 - Formulation of Syk inhibitors (2018-03-20),
8. 9796718 - 6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine (2017-10-24),
9. 9657023 - Polymorph of Syk inhibitors (2017-05-23),
10. 9567348 - Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors (2017-02-14),
11. 9562056 - Imidazopyridines Syk inhibitors (2017-02-07),
12. 9505785 - Pyridone and aza-pyridone compounds and methods of use (2016-11-29),
13. 9382256 - Formulation of Syk inhibitors (2016-07-05),
14. 9249123 - Pyridinones/pyrazinones, method of making, and method of use thereof (2016-02-02),
15. 9212191 - 6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor (2015-12-15),
Company Overview
Gilead Connecticut, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. With a strong emphasis on antiviral therapies, Gilead specializes in treatments for various infectious diseases, including HIV, hepatitis, and influenza. The company is also engaged in research aimed at addressing unmet medical needs in oncology and inflammatory diseases. Headquartered in Foster City, California, Gilead operates globally, leveraging advanced scientific expertise to enhance patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Gilead Connecticut, Inc. USPTO Patent Assignee Logo
30 Patents

#15 in Foster City, CA

#2,682 in California

#11,279 in US

#21,912 in the World

Foster City, CA (US)
Foster City, CA, United States of America

Gilead Connecticut, Inc.

Forward Citations = 446

36 inventors:

goldMedal Scott A Mitchell (23 out of 67 patents)

silverMedal Kevin S Currie (22 out of 72 patents)

bronzeMedal Peter A Blomgren (18 out of 53 patents)

4.  Jeffrey E Kropf (16 out of 45 patents)

5.  Jianjun Xu (16 out of 40 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gilead Connecticut, Inc.. Retrieved from https://idiyas.com/company/gilead-connecticut

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…